We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Top Factors Driving Global POC Glucose Monitoring Devices Market

By LabMedica International staff writers
Posted on 23 Feb 2018
The global market for POC blood glucose monitoring devices is expected to grow at a CAGR of over 8% during the period 2018-2022, driven mainly by public and private initiatives to reduce diabetic cases. More...
These are the latest findings of Technavio Research, (London, UK), a global technology research and advisory company.

There has been an increase in the incidence of lifestyle diseases such as diabetes, which is of three types: Type 1, Type 2, and gestational diabetes (diabetes during pregnancy). The CDC estimates that, as of 2017, more than 30 million individuals in the US had diabetes, out of which over 95% had Type 2 diabetes. Heredity, obesity, unhealthy diet, and sedentary lifestyle are the main factors responsible for Type 2 diabetes. The growing aged population and increasing number of overweight individuals is leading to a higher number of adults suffering from diabetes.

In order to prevent or delay Type 2 diabetes, the US government is introducing several programs under the national diabetes prevention program in association with the CDC, such as the CDC-recognized diabetes prevention lifestyle change program. The increase in such public and private initiatives to reduce the number of diabetic cases will have the highest positive impact on the growth of the POC blood glucose monitoring devices market.

Based on product, the global POC blood glucose monitoring devices market was dominated by the consumables segment in 2017 with the largest share of 67%. The largest share of the consumables segment was due to continuous usage of consumables while performing blood glucose monitoring tests, especially for diabetic patients. The growing preference for disposable consumables to reduce the risk of contamination is expected to further boost the demand for consumables among various healthcare centers. Based on end-user, the hospitals and clinics segment accounted for the largest share of the blood glucose monitoring devices market in 2017 due to the increasing number of diabetic cases in the US.

The POC blood glucose monitoring devices market is witnessing growth in the Americas due to increasing focus on advanced technologies and development of non-invasive wearable POC glucose monitoring devices. The market for blood glucose monitoring devices in the region will continue to grow during the period 2018-2022, driven by the availability of favorable reimbursements for POC blood glucose monitoring devices and increasing number of FDA approvals for technologically-advanced products. Additionally, the increasing cases of hyperglycemia will lead to an increase in the need for blood glucose tests and higher demand for POC blood glucose monitoring devices in the region over the next five years.

“The increasing diabetic patient pool also increases the economic burden due to which several public and private organizations around the world are engaged in activities to increase awareness and reduce the incidence of Type 2 diabetes which can be controlled or averted by adopting lifestyle changes. These awareness initiatives augur well for the growth of the market as they will encourage increased adoption of POC blood glucose monitoring devices,” said a senior analyst at Technavio.

Related Links:
Technavio Research


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Serological Pipet Controller
PIPETBOY GENIUS
New
Varicella Zoster Test
ZEUS ELISA Varicella Zoster IgG Test System
New
Droplet Digital PCR System
QX600 AutoDG
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Ear wax could be a possible screening medium for Parkinson’s disease (Photo courtesy of 123RF)

Earwax Test Accurately Detects Parkinson’s by Identifying Odor Molecules

Current tests for Parkinson’s disease (PD) rely heavily on clinical scales and neuroimaging, which are often subjective, expensive, and ill-suited for routine screening. Since most treatments only slow... Read more

Molecular Diagnostics

view channel
Image: Cord blood proteomics can identify biomarkers of early-onset neonatal sepsis (Photo courtesy of JCI Insight (2025). DOI: 10.1172/jci.insight.193826)

Umbilical Cord Blood Test Can Detect Early Sepsis in Preterm Infants

Diagnosing early onset sepsis (EOS) in preterm infants is particularly difficult due to the lack of specific clinical signs, leading to widespread use of antibiotics while awaiting culture results.... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: NGS can detect one tumor cell among a million healthy cells from a simple blood sample (Photo courtesy of Shutterstock)

New Tool Detects Breast Cancer Relapses Five Years in Advance

Relapse detection in patients with solid tumors—particularly hormone receptor-positive (HR+) breast cancer—remains a major clinical challenge, as many patients initially respond well to treatment but later... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.